Eisai
4523.T
#2131
Rank
NZ$16.21 B
Marketcap
NZ$57.45
Share price
4.38%
Change (1 day)
13.24%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): NZ$3.54

According to Eisai's latest financial reports the company's current EPS (TTM) is NZ$1.55. In 2022 the company made an earnings per share (EPS) of NZ$2.87 a decrease over its 2021 EPS that were of NZ$12.74.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$3.5423.45%
2022NZ$2.87-77.48%
2021NZ$12.74-41.88%
2020NZ$21.92-0.94%
2019NZ$22.1352.59%
2018NZ$14.50124.17%
2017NZ$6.47-49.42%
2016NZ$12.7937.08%
2015NZ$9.33-11.75%
2014NZ$10.57-3.23%
2013NZ$10.93-18.56%
2012NZ$13.42-15.51%
2011NZ$15.88-3.75%
2010NZ$16.50-1.36%
2009NZ$16.73